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Mathematical  models  predict  that  the  prevalence  of infection  in different  communities  where  an  infec-
tious  disease  is disappearing  should  approach  a geometric  distribution.  Trachoma  programs  offer  an
opportunity  to  test  this  hypothesis,  as the  World  Health  Organization  (WHO)  has  targeted  trachoma  to
be  eliminated  as  a public  health  concern  by the  year  2020. We  assess  the  distribution  of the  community
prevalence  of  childhood  ocular  chlamydia  infection  from  periodic,  cross-sectional  surveys  in two  areas
of Ethiopia.  These  surveys  were  taken  in a  controlled  setting,  where  infection  was  documented  to be
disappearing  over  time.  For  both  sets of surveys,  the  geometric  distribution  had  the  most  parsimonious
ﬁt  of  the  distributions  tested,  and  goodness-of-ﬁt  testing  was  consistent  with  the  prevalence  of  each
community  being  drawn  from  a geometric  distribution.  When  infection  is  disappearing,  the  single  suf-
ﬁcient  parameter  describing  a geometric  distribution  captures  much  of the  distributional  informationeometric distribution found  from  examining  every  community.  The  relatively  heavy  tail  of the  geometric  suggests  that  the
presence  of an  occasional  high-prevalence  community  is  to be  expected,  and  does  not  necessarily  reﬂect
a transmission  hot  spot  or  program  failure.  A  single  cross-sectional  survey  can  reveal  which  direction  a
program is  heading.  A  geometric  distribution  of  the prevalence  of  infection  across  communities  may  be
an encouraging  sign,  consistent  with  a  disease  on  its way  to eradication.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND. Introduction
Trachoma is the leading infectious cause of blindness
orldwide(Resnikoff et al., 2004). Mass, community-wide, oral
zithromycin treatments have proven effective in reducing the
revalence of the causative agent, Chlamydia trachomatis(Schachter
t al., 1999; Chidambaram et al., 2006; House et al., 2009; Lietman
t al., 1999; Gebre et al., 2011). Hygiene programs and latrine con-
truction are also thought to reduce transmission (Emerson et al.,
000). In some areas, infection is disappearing even in the absence
f a dedicated treatment program (Chidambaram et al., 2006; Dolin
∗ Corresponding author at: University of California, San Francisco, F. I. Proctor
oundation, Room S309 Medical Sciences, UCSF 513 Parnassus Ave, San Francisco,
A  94143-0944, USA. Tel.: +1 4155022662; fax: +1 4154760527.
E-mail addresses: tom.lietman@ucsf.edu, susan.ford@ucsf.edu (T.M. Lietman).
ttp://dx.doi.org/10.1016/j.epidem.2015.03.003
755-4365/© 2015 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
et al., 1998; Hoechsmann et al., 2001; Jha et al., 2002). Infec-
tion may  be going away because of mass antibiotic distribution,
improved hygiene, or secular changes. Regardless of the mech-
anism, public health stakeholders need to assess whether their
programs are a success or failure. Progressive reduction of the mean
prevalence of infection in a region towards zero would certainly
be an encouraging trend. However, monitoring large numbers of
villages longitudinally can take up scarce resources, and has not
been done consistently outside a few research programs. Programs
would beneﬁt if cross-sectional surveys alone could reveal whether
infection was headed towards elimination.
Mathematical models of infectious disease transmission sug-
gest that as a disease disappears, the only stationary distribution
for the expected prevalence of infection occurs when elim-
ination has been achieved in all communities(Brauer et al.,
2008). However, the distribution of the prevalence in those
communities where infection still remains may approach a
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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uasi-stationary distribution (Cavender, 1978; Nåsell, 1999, 1996).
n stochastic Susceptible-Infectious-Susceptible (SIS) models, this
uasi-stationary distribution can be approximated by a geometric
istribution (Cavender, 1978; Nåsell, 1999, 1996). Speciﬁcally, if
e assume a reproduction number at invasion (R0) distinctly less
han one, and a refuge of one permanently infected individual in
ach community, then the number of infections in a set of uni-
orm, ﬁxed-size communities approaches a geometric distribution
s the population size of communities gets larger (Nåsell, 1996).
imulations suggest that even with moderate population sizes, the
eometric distribution or its continuous analog, the exponential
istribution, are excellent approximations (Nåsell, 1999, 1996; Ray
t al., 2007). This has been found for models of infection disap-
earing due to low transmission or due to repeated mass antibiotic
istributions (Nasell, 1999; Ray et al., 2007). Note that these models
ypically have assumed homogeneity within and between commu-
ities (Blake et al., 2009; Ray et al., 2009). Thus, the geometric
istribution may  or may  not ﬁt well to ﬁeld data, where these
ssumptions would likely not strictly hold.
Recent trachoma surveys have assessed the prevalence of infec-
ion in multiple communities biannually over several years. In each
tudy, communities were participating in an intensive treatment
rogram, and infection was documented to be decreasing over
ime. If the underlying conditions which promote transmission
re similar enough in an area, then each community could be
egarded as a separate sampling from a single distribution. Here,
e test the hypothesis that a geometric distribution describes the
revalence of infection in different communities where infection
s disappearing.
. Methods
We  considered results from the TEF study in Gurage, Ethiopia,
nd the TANA study in Amhara Ethiopia; in each, children from 24
ommunities were longitudinally monitored for ocular chlamyd-
al infection (House et al., 2009; Gebre et al., 2011; Holm et al.,
001; Lakew et al., 2009a; Porco et al., 2009). Children are consid-
red a core-group for ocular chlamydia infection and are therefore
he most important population to monitor (House et al., 2009).
n the TEF study, 1–5 year-old children were monitored biannu-
lly from randomly selected communities treated biannually for
 years (Lakew et al., 2009a). In the TANA study, 0–9 year-old
hildren were monitored biannually from randomly selected com-
unities treated annually or biannually for 42 months (Gebre et al.,
012). In order to characterize the distribution of infection when
nfection is disappearing, we included cross-sectional visits after
t least two mass antibiotic distributions and where the mean
revalence of infection was lower than seen 12 months previ-
usly (Chidambaram et al., 2006; Lakew et al., 2009b). For display
urposes only, we produced an empirical distribution of each cross-
ectional survey by assuming that each community’s contribution
as the Bayesian posterior derived from the observed prevalence
nd a non-informative, uniform prior (thus a beta distribution). To
ssess possible geographical clustering in TANA, where GPS coordi-
ates were available, we conducted a permutation test of Moran’s
 deﬁning neighboring communities as those sharing a vertex in a
elaunay triangulation.
For each of the cross-sectional surveys of prevalence, we
ssessed the ﬁt of 8 discrete distributions. Three had a single
ontinuous parameter: the geometric, binomial, and Poisson dis-
ributions. Four had two continuous parameters, and with the
ppropriate shape parameter included the geometric distribution
s a special case: discrete Weibull, negative binomial, beta bino-
ial (at least asymptotically approaching a geometric distribution
s the population size increases), the zero-inﬂated geometric, andics 11 (2015) 85–91
the zero-inﬂated Poisson distributions (Johnson et al., 1993). Sev-
eral cross-sectional surveys were available for each of the two
studies. In order to combine data from the available visits, for
each of the 2-parameter distributions we ﬁtted a single overall
shape parameter per study, but a different scale parameter for
each available time point (of which there were 3 in TEF and 4
in TANA). Note that we  chose to parameterize the zero-inﬂated
geometric and Poisson allowing a different proportion of zeros at
each visit, but a single geometric scale parameter for all visits (see
Appendix). As a sensitivity analysis for the 2-parameter distribu-
tions, we ﬁtted each cross-sectional survey separately, allowing a
unique shape and scale parameter for each cross-sectional visit.
Since the 24 different communities in each of the two  studies
had differing numbers of individuals, we parameterized such that
the ﬁtted scale parameter for each cross-sectional survey repre-
sented the mean proportion of the distribution; note that this mean
proportion of the distribution was  not necessarily the mean propor-
tion of the data (Appendix A). Since post-treatment distributions
were right-tailed, the ﬁrst shape parameter of the beta binomial
distribution was  treated as the shape parameter, and the second
shape parameter as the scale parameter (see re-parameterizations
in the Appendix). Each distribution was assessed by determining
the parameter values that optimized the likelihood of the observed
data, and ranked by the sample size-corrected Akaike Information
Criterion (AICc) (Burnham and Anderson, 1998). The uncertainty
of the parameter estimates was  assessed with bias-corrected 95%
percentile bootstrap conﬁdence intervals with 999 resamples. We
performed goodness-of-ﬁt testing with the chi-squared statistic,
binning prevalence into 5% intervals and comparing versus the
geometric distribution with the optimum scale parameter. We
determined the P-value for the observed data by selecting 999 sam-
ples from the best-ﬁt geometric distribution for each study visit,
and treated each sample in the same manner as the observed data.
As sensitivity analyses, we  ﬁtted pre-treatment data from the
two study regions before a program was  initiated (time 0 months
in Table 1 and the black curves in Fig. 1 and b); infection was not
thought to be disappearing, and thus a geometric distribution was
not expected. In addition, we  estimated community prevalence
from a stochastic SIS model, assuming R0 = 0.5 (infection disap-
pearing), R0 = 1.0, R0 = 1.5, or R0 = 2.0 (infection not disappearing),
and creating a sample of 50 children from each of 24 communities
(Lietman et al., 2011). We  determined the quasi-stationary distri-
bution of the prevalence of infection pre-treatment by constructing
an N × N matrix representing the N Kolmogorov forward equa-
tions without the zero state; the eigenvector associated with the
largest eigenvalue of this matrix was  taken as the quasi-stationary
distribution(Brauer et al., 2008; Nasell, 1999; Ray et al., 2007).
The quasi-stationary distribution after three annual mass distribu-
tions with 80% coverage was  estimated with 1000 simulations. In
order to assess whether 24 communities were sufﬁcient to distin-
guish between different distributions, we ﬁtted multiple samples
of 24 simulated communities from geometric and discrete Weibull
distributions. All calculations were performed in Mathematica 9.0
(Wolfram Research, Champaign, Illinois).
Data were from studies registered with ClinicalTrials.gov
(NCT00221364 and NCT00322972) and approved by the National
Ethics Review Committee of the Ethiopian Science and Technology
Agency and the UCSF IRB (10-02630 and 10-02576).
2.1. Role of the funding sourceThe sponsors of the study had no role in trial design, data collec-
tion, data analysis, data interpretation, or writing of the report. TL
had full access to all the data in the study and had ﬁnal responsibility
for the decision to submit for publication.
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Table  1
Prevalence of ocular chlamydial infection in longitudinal studies of trachoma in Ethiopia.
Prevalence of Infection
Communities Mean prevalence Standard deviation of prevalence Geometric distribution
goodness of ﬁt test
(P-value)
TEF Ethiopia
0 Months 16 0.529 0.218 0.03
12  Months 16 0.069 0.109 0.23
18  Months 16 0.032 0.037 0.58
24  Months 16 0.020 0.022 0.30
TANA  Ethiopia
0 Months 24 0.394 0.153 0.03
18 Months 24 0.043 0.050 0.29
24 Months 24 0.036 0.041 0.12
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36  Months 24 0.026 
. Results
Visits from the two studies were included if communities had
eceived at least two mass antibiotic distributions and if the infec-
ion was documented to have decreased from 12 months earlier
ere included. The 2 and 6 month visits from TEF and the 6 and 12
onth visits from TANA were excluded because they were after a
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a
b
ig. 1. (a) Distribution of the prevalence of ocular chlamydia infection in 1-5 year-
ld  children in 24 communities in the TEF study, Gurage, Ethiopia. (Lakew et al.,
009a) Communities were treated biannually with mass oral azithromycin. The dis-
ribution of infection for each cross-sectional survey is displayed as a density plot,
n  which each community’s contribution is the Bayesian posterior derived from the
bserved prevalence and a non-informative, uniform prior. The prevalence clearly
ecreases from baseline (black curve) to post-treatment visits at 12, 18, and 24
onths (progressively lighter grey curves). (b) Distribution of the prevalence of
cular chlamydia infection in 0–9 year-old children in 24 communities in the TANA
tudy, Amhara, Ethiopia. (Gebre et al., 2012) Communities were treated annually or
iannually. The prevalence decreases from baseline (black curve) to post-treatment
isits at 18, 24, 30, and 36 months (progressively lighter grey curves).0.025 0.89
0.037 0.74
single treatment. The post-treatment mean prevalence of infection
in the two  studies varied from 1.5% to 10.9% (Table 1), decreas-
ing after mass treatment. Density plots of the community-level
prevalence over time are displayed in Fig. 1. In TANA, where GPS
was available, we  were unable to demonstrate statistically signiﬁ-
cant geographical clustering for any post-treatment visit (Moran’s
I: P = 0.32 for 18 months, P = 0.30 for 24 months, P = 0.14 for 30
months, P = 0.64 for 36 months).
We determined the parameter values which maximized the
likelihood of obtaining the observed data for the 7 distributions:
geometric, binomial, Poisson, discrete Weibull, negative binomial,
beta binomial, zero-inﬂated geometric, and zero-inﬂated Poisson
distributions (Table 2). In each case, the geometric distribution
had the lowest (best) AICc. The binomial and Poisson distributions
were the other single parameter distributions tested and offered far
lower (worse) likelihoods. Note that the geometric distribution is a
special case of the two-parameter distributions: discrete Weibull,
negative binomial, and beta binomial (at least asymptotically), and
the zero-inﬂated geometric distributions; thus with appropriate
parameter choices, each can mimic  a geometric distribution and
achieve a likelihood of the observed data as least as high as that
found with the geometric (with the exception of the zero-inﬂated
geometric since we chose to use a single geometric scale parameter
for each cross-sectional survey in a study, allowing the proportion
that were zero to vary at each time point). Since none of these two-
parameter distributions offered a signiﬁcantly better ﬁt than the
geometric, the AICc was larger for these distributions. This sug-
gests that these two-parameter distributions are less parsimonious
than the geometric. The 95% conﬁdence intervals for the estima-
tion of the shape parameters for these two-parameter distributions
included one, which in these parameterizations were consistent
with the geometric (Table 2). Note that when we treated each
individual cross-sectional survey separately allowing the shape
parameter to vary with each visit, either the geometric or the zero-
inﬂated geometric had the best AICc (for individual TANA visits,
see Appendix B); the 95% CIs of shape parameter of the other three
2-parameter distributions included one for each separate visit. If
the community-level prevalence of infection were indeed from a
geometric distribution, how often would we have found results as
close to a geometric as observed? With goodness-of-ﬁt testing, we
were unable to reject the hypothesis that the observed data from
each entire study, or from any single post-treatment visit within a
study, came from a geometric distribution (Table 1).
As sensitivity analyses, simulations of an SIS model with mass
action and R0 = 0.5 were used to construct a dataset similar to the
Ethiopian data with 24 communities evaluated at 4 different time
points. The geometric offered the optimal AICc, and in no case did
the addition of a second parameter result in a statistically superior
88 T.M. Lietman et al. / Epidemics 11 (2015) 85–91
Table 2
Model ﬁt of the distribution of the community-level prevalence of infection in Ethiopian trachoma studies.
TEF 12, 18, and 24 months Shape parameter No. of parameters LogeLikelihood AICc
Geometric 4 −125.79 263.576
Negative binomial 0.824 (0.364 to 1.663) 5 −125.58 265.165
Beta  binomial 0.742 (0.335 to 1.526) 5 −125.76 265.528
Discrete Weibull 0.999 (0.750 to 1.289) 5 −125.79 265.580
Zero-inﬂated Geometric 0.956 (0.934 to 0.972) 5 −130.91 275.815
Poisson 4 −153.42 318.838
Binomial 4 −157.68 327.356
TANA  18, 24, 30, and 36
months
Shape parameter No.of parameters LogeLikelihood AICc
Geometric 5 −157.544 329.089
Beta  binomial 0.926 (0.674 to 1.412) 6 −157.435 330.871
Negative binomial 0.960 (0.462 to 1.820) 6 −157.535 331.070
Zero-inﬂated Geometric 0.957 (0.935 to 0.976) 6 −157.894 331.788
Discrete Weibull 1.030 (0.792 to 1.363) 6 −158.390 332.779
Poisson 5 −179.668 373.335
Binomial 5 −181.924 377.849
ﬁ
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nt (likelihood ratio test, P > 0.05). Similar sized sets of communities
imulated from discrete Weibull distributions with shape parame-
ers of 0.5 and 2.0 were easily distinguishable from the geometric
P < 0.05), with the Weibull distribution having the optimal AICc.
he model selection process correctly identiﬁed samples taken
rom discrete Weibull distributions with shape parameters 0.5 and
.0. Empirical, pre-treatment surveys from the two Ethiopian areas
tudied were not consistent with a geometric distribution (Table 2).
imulations of an SIS model with mass action and R0 = 1.0, 1.5, and
.0 (without treatment) were used to construct datasets similar to
he Ethiopian data with 24 communities evaluated at 4 different
ime points. In all cases, the Poisson and the binomial distribution
ach had a far lower (better) AICc than the geometric distribu-
ion. Similar sets with an estimated treated reproduction number of
t = 1.0, 1.5, and 2.0 also were better ﬁt by the Poisson and binomial
han the geometric (for Rt = 1.0 see Appendix C).
. Discussion
When assessing whether an infectious disease is on its way to
limination, survey of infection in every community in a region over
ime may  be infeasible due to the costs of collection and process-
ng. However, if the community-level cross-sectional prevalence
f infection in an area can be approximated by a geometric distri-
ution, then a single cross-sectional sampling of communities can
rovide an accurate assessment of infection in an area. Here, we
ssessed two large, population-based surveys recently performed
n multiple communities in controlled settings where transmis-
ion conditions were similar and constant, and where trachoma
as known to be disappearing due to programmatic activity. In
ach case, the geometric distribution ﬁtted the observed data better
han the other distributions tested. Furthermore, we were unable
o reject the hypothesis that each prevalence was drawn indepen-
ently from a geometric distribution in these two  settings where
rachoma was known to be disappearing. Much of the distribu-
ional information available from examining every community is
aptured by the single, sufﬁcient parameter of a geometric distri-
ution.
Since a geometric distribution has a relatively heavy tail, out-
iers are to be expected. While we cannot discount the possibility
hat a high prevalence village has inherently higher transmission
han its neighbors, this need not be hypothesized; occasional high
revalence communities are to be expected even from a set of
ommunities with identically transmission characteristics, and do
ot necessarily reﬂect a hot spot for transmission or a programfailure. Models predict that infection will still disappear from the
high prevalence communities in the tail of this distribution (Ray
et al., 2007, 2009). Empirical studies support this. Reports from
Nepal, Tanzania, and the Gambia have found that the prevalence
of infection in the most severely affected village in an otherwise
hypo-endemic area decreases in the absence of treatment (Jha et al.,
2002; Gaynor et al., 2003; Solomon et al., 2004; Burton et al., 2010).
Longitudinal studies that focused on the most severely affected
community in an area may  have led researchers to interpret this
regression to the mean as enhanced efﬁcacy of antibiotics and other
interventions, relative to studies which included a control group
(Gebre et al., 2011; Gaynor et al., 2003; Solomon et al., 2004; Stoller
et al., 2011; West et al., 2006).
Recent models ﬁtted to data from areas moderately endemic
for trachoma suggest the possibility of positive feedback (Lietman
et al., 2011); that is, additional infection in a community may
increase the per-susceptible risk of infection more than the
proportional increase assumed by the mass-action model. In
meso-endemic areas this may  result in a bi-modal distribution of
prevalence, with a peak at elimination, and a second peak around
an endemic equilibrium (Lietman et al., 2011). Note though that
even a positive (or negative) feedback model should behave as a
mass-action SIS model at a low enough prevalence, and thus the
geometric distribution would still be expected. We would expect a
mixture of two  distributions if a survey area included distinct areas
of low and high transmission. If the unit of the survey was  not a
single community, but a cluster of communities, we would expect
the convolution of several geometric distributions (i.e. a negative
binomial distribution with a shape parameter greater than one).
There are many limitations of this study. These 2–4 years lon-
gitudinal studies show decrease in prevalence, but do not follow
to complete elimination. The goodness-of-ﬁt testing assumes inde-
pendent sampling from an identical distribution; while the samples
were exchangeable, there may  be geographical correlations. None
of the sentinel communities in either TEF or TANA were contigu-
ous, and in TANA, where GPS was available, we were unable to
demonstrate any signiﬁcant geographical clustering. Note that any
correlation would have made it more difﬁcult to exclude a geomet-
ric distribution, hence in that sense our analysis was conservative.
Likewise, the prevalence of infection in treatment arms in TANA
was not signiﬁcantly different; separation by treatment arm would
have resulted in smaller datasets and more difﬁcult exclusion of
the geometric distribution.
The endgame for disease control offers special challenges. While
districts or subdistricts may  meet thresholds for control, concern
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or missing higher prevalence communities has led some to argue
hat programs need to examine every community. Knowledge that
ommunity-level prevalence approximates a geometric distribu-
ion, and that the scale of the distribution can be estimated from
 survey sample, may  allow programs the conﬁdence they need to
onserve resources. Population-based surveys of all communities in
rachoma-endemic areas would be an enormous undertaking, and
ppears to be unnecessary. Programs can assess whether they are
n track towards elimination by a single cross-sectional survey. If
he distribution of the community prevalence of infection in a par-
icular area is consistent with a geometric distribution, this may
e a good sign, since this would not be expected in areas where
nfection is not disappearing (Nåsell, 1996; Lietman et al., 2011).
ote that elimination would only be expected to eventually occur
f conditions remain the same. An increase in transmission due to
iscontinuation of programmatic activity of deterioration of socio-
conomic status could prevent elimination. Additional studies will
e necessary to determine whether the prevalence of the clinical
igns of infection on which programs rely so heavily can also be
pproximated by a geometric distribution.
Can trachoma be eradicated? The strains of chlamydia that cause
he disease are only transmitted between humans. No vaccine has
een shown efﬁcacious. While the WHO  recommends hygiene and
atrine programs, no non-antibiotic measure has yet been proven
o decrease infection (Emerson et al., 2000; Stoller et al., 2011).
ass antibiotics distributions have proven effective in cluster-
andomized trials, and have so far been well tolerated (Schachter
t al., 1999; Chidambaram et al., 2006; House et al., 2009). Tra-
homa has been disappearing in some areas, even in the absence of
 dedicated trachoma program (Hoechsmann et al., 2001; Jha et al.,
002; Dolin et al., 1997). This report suggests that if efforts are
ontinued, infection will eventually disappear in previously hyper-
ndemic areas of Ethiopia. If these are representative of other
everely affected regions, if trachoma programs can be maintained,
nd if antibiotic resistance does not evolve, then global eradication
f trachoma may  indeed be feasible.
unding
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Visit AICc Distribution 
TANA baseline 173.55 Negative Binomial 
187.12  Discrete Weibull 
190.30  Poisson 
193.53 Zero-inﬂated Poisson 
193.72  Geometric 
196.95 Zero-inﬂated Geometric 
218.73  Binomial 
TANA  18 months 105.21 Geometric 
108.16 Discrete Weibull 
108.19  Negative Binomial 
108.44  Zero-inﬂated Geometric ics 11 (2015) 85–91 89
Appendix A. The discrete distributions were parameterized
such that the prevalence of infection would not, on average,
be affected by that community’s population size; the scale
parameter which was maximized was the probability of an
individual being infected at that cross-sectional survey, in
that study. The 2-parameter distributions, were
parameterized such that the shape parameter would be the
same for all visits, and would equal one when the
distribution represented a geometric distribution
(asymptotically in the case of the beta binomial
distribution). The probability mass functions used are:
Geometric distribution:
(
1− 11+njpt
)i
1+njpt
(
1− 11+njpj
)i
1+njpj
Poisson distribution:
e
−npj (njpj)
i
i!
e
−njpj (njpt)
i
i!
Binomial distribution: (1 − pt)−i+nj pit
(
nj
i
)
Discrete Weibull distribution:
(
nj pt
1+nj pt
)p˛
j −
(
nj pt
1+nj pt
)(1+pt )˛
Negative Binomial distribution:(
˛
 ˛ + nj pt
)˛(
1 − ˛
 ˛ + nj pt
)i(
 ˛ + i − 1
 ˛ − 1
)
:
Beta Binomial distribution:(
nj
i
)
(  ˛ + i − 1)!
(i − 1)!
(
 ˛ − pt˛
pt
+ nj − i − 1
)
!(
nj − i
)
!(
 ˛ +  ˛ − pt˛
pt
+ nj − 1
)
!
nj!
Zero-inﬂated Geometric distribution:⎧⎨
⎩ ˛t
(
1 −
(
1/1 + njp
))i
1 + njp
1 − ˛t 0
Zero-inﬂated Poisson distribution:⎧⎨
⎩ ˛t
e−nj p
(
nj p
)i
i!
1 − ˛t 0
where  ˛ is the reparameter-
ized shape parameter, t is the time point, j is the community, pt is
the mean prevalence of the distribution for the time point t, nj is the
number of individuals in the jth community, and i is the number
infected in the community. For the two  zero-inﬂated distributions,
we allowed the shape parameter to vary between visits, keeping
the prevalence parameter constant.
Appendix B. Model ﬁtting for individual visits of TANA,
ranked by AICc of models for that visit. The best-ﬁt shape
and scale parameters are included.
Parameters logLikelihood Shape Scale
5 –80.107 8.352 0.395
5 −86.894 1.345 1.000
4 −90.097 0.397
5 −90.097 0.397 0.000
4 −91.809 0.395
5 −91.809 0.395 0.000
4 −104.314 0.397
4 −47.551 0.043
5 −47.411 1.101 0.051
5 −47.429 1.270 0.043
5 −47.551 0.043 0.000
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A
Parameters logLikelihood Shape Scale
5 −52.150 0.054 0.204
4 −55.297 0.043
4 −56.338 0.043
4 −43.304 0.036
5 −43.071 0.053 0.327
5 −43.256 1.066 0.040
5 −43.270 1.160 0.036
5 −43.287 0.037 0.034
4 −48.179 0.036
4 −48.711 0.036
4 −28.885 0.015
5 −28.294 0.032 0.529
5 −28.532 0.020 0.257
5 −28.663 0.590 0.015
5 −28.695 0.855 0.013
4 −31.681 0.015
4 −31.847 0.015
4 −37.804 0.026
5 −37.499 0.032 0.173
5 −37.530 0.853 0.021
5 −37.539 0.655 0.026
5 −38.745 0.047 0.440
4 −44.511 0.027
4 −45.028 0.027
A
S
b
P
c
t
t
e
Parameters logLikelihood Shape Scale
1 −73.183 0.395
2 −73.183 0.572 1.000
2 −73.183 1120,000 0.397
1 −78.462 0.000
2 −100.814 1.223 0.395
1 −104.917 0.000
2 −104.917 0.573 0.397
2 −73.419 4.261 0.043
2 −73.546 1.669 0.051
2 −77.972 0.197 0.043
1 −79.152 0.000
2 −79.152 0.189 0.204
1 −83.477 0.043
1 −88.804 0.043
2 −80.429 3.944 0.036
2 −81.297 1.506 0.327
1 −86.161 0.040
2 −86.161 0.257 0.036
2 −88.769 0.268 0.034
1 −97.720 0.036
1 −109.989 0.036
2 −85.053 4.651 0.015
2 −87.390 1.401 0.529
2 −90.243 0.345 0.257
1 −92.052 0.015
2 −92.052 0.331 0.013
1 −102.983 0.015
1 −119.651 0.015
2 −53.662 1.802 0.026
2 −53.799 5.766 0.1730 T.M. Lietman et al. / E
ppendix B (Continued)
Visit AICc Distribution 
117.63 Zero-inﬂated Poisson 
120.70  Poisson 
122.78 Binomial 
TANA  24 months 96.71 Geometric 
99.48 Zero-inﬂated Poisson 
99.84  Discrete Weibull 
99.87 Negative Binomial
99.91  Zero-inﬂated Geometric 
106.46  Poisson 
107.53 Binomial 
TANA  30 months 67.88 Geometric 
69.92 Zero-inﬂated Poisson 
70.40 Zero-inﬂated Geometric
70.66 Negative Binomial
70.72  Discrete Weibull 
73.47  Poisson 
73.80  
TANA  36 months 85.71 Geometric 
88.33 Zero-inﬂated Geometric 
88.39  Discrete Weibull 
88.41  Negative Binomial 
90.82 Zero-inﬂated Poisson
99.13  Poisson 
100.16 Binomial 
ppendix C. Model ﬁtting for individual visits of simulated
IS model, ranked by AICc of models for that visit. The
est-ﬁt shape and scale parameters are included.
arameters for the model include: population of 50
hildren per community, R0 = 2.6 (in the absence of
reatment), estimated Rt = 1.0 (in the presence of
reatment)(Melese et al., 2004), 80% coverage with 100%
ffective antibiotic, rate of recovery 1/52 weeks.
Visit AICc Distribution 
Simulated baseline 148.55 Poisson 
150.94  Zero-inﬂated Poisson 
150.94  Negative Binomial 
159.10 Binomial 
206.20  Discrete Weibull 
212.02  Geometric 
214.41  Zero-inﬂated Geometric 
Simulated 18 months 151.41 Negative Binomial 
151.66  Discrete Weibull 
160.52  Zero-inﬂated Poisson 
160.49  Geometric 
162.87  Zero-inﬂated Geometric 
169.14  Poisson 
179.79  Binomial 
Simulated 24 months 165.43 Negative Binomial 
167.17  Discrete Weibull 
174.50  Geometric 
176.89  Zero-inﬂated Geometric 
182.11  Zero-inﬂated Poisson 
197.62  Poisson 
222.16  Binomial 
Simulated 30 months 174.68 Negative Binomial 
179.35  Discrete Weibull 
185.06  Zero-inﬂated Poisson 
186.29  Geometric 
188.68  Zero-inﬂated Geometric 
208.15  Poisson 
241.48  Binomial 
Simulated 36 months 111.89 Discrete Weibull 
112.17  Negative Binomial 
112.64 Zero-inﬂated Poisson
112.64  Poisson 
113.73  Binomial 
118.57  Geometric 
120.96  Zero-inﬂated Geometric 2 −54.033 0.078 0.021
1 −55.229 0.026
1 −55.775 0.440
1 −58.193 0.027
2 −58.193 0.073 0.027
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